ICOS and bladder transitional cell carcinoma: In addition to THCA, the expression of ICOS in BLCA, COAD, DLBC, GBM, LGG, OV, PAAD, READ, SKCM, TGCT, and UCS patients in the comprehensive database was also significantly increased (Fig. 1B).